New Owner
Cephalon - Gemin X Pharmaceuticals
Cephalon acquires Gemin X Pharmaceuticals
Announced: March 21, 2011
Type: Acquisition
Disposition: Combined
Terms: Cash & Stock
Status: Complete
Amount: $ 525,000,000